157 related articles for article (PubMed ID: 12359053)
1. Expression of cyclin-dependent kinase inhibitor p27/Kip1 and AP-1 coactivator p38/Jab1 correlates with differentiation of embryonal rhabdomyosarcoma.
Tsuchida R; Miyauchi J; Shen L; Takagi M; Tsunematsu Y; Saeki M; Honna T; Yamada S; Teraoka H; Kato JY; Mizutani S
Jpn J Cancer Res; 2002 Sep; 93(9):1000-6. PubMed ID: 12359053
[TBL] [Abstract][Full Text] [Related]
2. Jab1 expression is associated with inverse expression of p27(kip1) and poor prognosis in epithelial ovarian tumors.
Sui L; Dong Y; Ohno M; Watanabe Y; Sugimoto K; Tai Y; Tokuda M
Clin Cancer Res; 2001 Dec; 7(12):4130-5. PubMed ID: 11751512
[TBL] [Abstract][Full Text] [Related]
3. The cytoplasmic shuttling and subsequent degradation of p27Kip1 mediated by Jab1/CSN5 and the COP9 signalosome complex.
Tomoda K; Kubota Y; Arata Y; Mori S; Maeda M; Tanaka T; Yoshida M; Yoneda-Kato N; Kato JY
J Biol Chem; 2002 Jan; 277(3):2302-10. PubMed ID: 11704659
[TBL] [Abstract][Full Text] [Related]
4. Jun activation domain binding protein 1 expression is associated with low p27(Kip1)levels in node-negative breast cancer.
Esteva FJ; Sahin AA; Rassidakis GZ; Yuan LX; Smith TL; Yang Y; Gilcrease MZ; Cristofanilli M; Nahta R; Pusztai L; Claret FX
Clin Cancer Res; 2003 Nov; 9(15):5652-9. PubMed ID: 14654548
[TBL] [Abstract][Full Text] [Related]
5. Skp2 and Jab1 expression are associated with inverse expression of p27(KIP1) and poor prognosis in oral squamous cell carcinomas.
Shintani S; Li C; Mihara M; Hino S; Nakashiro K; Hamakawa H
Oncology; 2003; 65(4):355-62. PubMed ID: 14707456
[TBL] [Abstract][Full Text] [Related]
6. Cytoplasmic localization of Jab1 and p27 Kip1 might be associated with invasiveness of papillary thyroid carcinoma.
Ahn J; Hong SA; Lee SE; Kim J; Oh YS; Park SJ; Chung YJ
Endocr J; 2009; 56(5):707-13. PubMed ID: 19461157
[TBL] [Abstract][Full Text] [Related]
7. Differentiation-associated expression and intracellular localization of cyclin-dependent kinase inhibitor p27KIP1 and c-Jun co-activator JAB1 in neuroblastoma.
Shen L; Tsuchida R; Miyauchi J; Saeki M; Honna T; Tsunematsu Y; Kato J; Mizutani S
Int J Oncol; 2000 Oct; 17(4):749-54. PubMed ID: 10995887
[TBL] [Abstract][Full Text] [Related]
8. Jun activation domain-binding protein 1 expression in breast cancer inversely correlates with the cell cycle inhibitor p27(Kip1).
Kouvaraki MA; Rassidakis GZ; Tian L; Kumar R; Kittas C; Claret FX
Cancer Res; 2003 Jun; 63(11):2977-81. PubMed ID: 12782606
[TBL] [Abstract][Full Text] [Related]
9. The Jab1/COP9 signalosome subcomplex is a downstream mediator of Bcr-Abl kinase activity and facilitates cell-cycle progression.
Tomoda K; Kato JY; Tatsumi E; Takahashi T; Matsuo Y; Yoneda-Kato N
Blood; 2005 Jan; 105(2):775-83. PubMed ID: 15353483
[TBL] [Abstract][Full Text] [Related]
10. Jab1 co-activation of c-Jun is abrogated by the serine 10-phosphorylated form of p27Kip1.
Chopra S; Fernandez De Mattos S; Lam EW; Mann DJ
J Biol Chem; 2002 Sep; 277(36):32413-6. PubMed ID: 12119282
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of localized p27Kip1 and potential role of Jab1/CSN5 in pancreatic cancer.
Fukumoto A; Ikeda N; Sho M; Tomoda K; Kanehiro H; Hisanaga M; Tsurui Y; Tsutsumi M; Kato JY; Nakajima Y
Oncol Rep; 2004 Feb; 11(2):277-84. PubMed ID: 14719054
[TBL] [Abstract][Full Text] [Related]
12. Interaction and colocalization of PGP9.5 with JAB1 and p27(Kip1).
Caballero OL; Resto V; Patturajan M; Meerzaman D; Guo MZ; Engles J; Yochem R; Ratovitski E; Sidransky D; Jen J
Oncogene; 2002 May; 21(19):3003-10. PubMed ID: 12082530
[TBL] [Abstract][Full Text] [Related]
13. Expression of cell cycle inhibitor p27Kip1 and its inactivator Jab1 in melanocytic lesions.
Ivan D; Diwan AH; Esteva FJ; Prieto VG
Mod Pathol; 2004 Jul; 17(7):811-8. PubMed ID: 15154004
[TBL] [Abstract][Full Text] [Related]
14. Jun activation domain-binding protein 1 expression in malignant lymphoma of the thyroid: its linkage to degree of malignancy and p27 expression.
Ito Y; Yoshida H; Matsuzuka F; Matsuura N; Nakamura Y; Nakamine H; Kakudo K; Kuma K; Miyauchi A
Anticancer Res; 2003; 23(5b):4121-5. PubMed ID: 14666612
[TBL] [Abstract][Full Text] [Related]
15. Tumor suppressor VDUP1 increases p27(kip1) stability by inhibiting JAB1.
Jeon JH; Lee KN; Hwang CY; Kwon KS; You KH; Choi I
Cancer Res; 2005 Jun; 65(11):4485-9. PubMed ID: 15930262
[TBL] [Abstract][Full Text] [Related]
16. Multiple functions of Jab1 are required for early embryonic development and growth potential in mice.
Tomoda K; Yoneda-Kato N; Fukumoto A; Yamanaka S; Kato JY
J Biol Chem; 2004 Oct; 279(41):43013-8. PubMed ID: 15299027
[TBL] [Abstract][Full Text] [Related]
17. Potential role of Jun activation domain-binding protein 1 as a negative regulator of p27kip1 in pancreatic adenocarcinoma.
Kouvaraki MA; Korapati AL; Rassidakis GZ; Tian L; Zhang Q; Chiao P; Ho L; Evans DB; Claret FX
Cancer Res; 2006 Sep; 66(17):8581-9. PubMed ID: 16951171
[TBL] [Abstract][Full Text] [Related]
18. Jun activation domain-binding protein 1 expression in oral squamous cell carcinomas inversely correlates with the cell cycle inhibitor p27.
Gao L; Huang S; Ren W; Zhao L; Li J; Zhi K; Zhang Y; Qi H; Huang C
Med Oncol; 2012 Dec; 29(4):2499-504. PubMed ID: 22311264
[TBL] [Abstract][Full Text] [Related]
19. Inverse expression of Jun activation domain binding protein 1 and cell cycle inhibitor p27Kip1: influence on proliferation in hepatocellular carcinoma.
Berg JP; Zhou Q; Breuhahn K; Schirmacher P; Patil MA; Chen X; Schäfer N; Höller TT; Fischer HP; Büttner R; Gütgemann I
Hum Pathol; 2007 Nov; 38(11):1621-7. PubMed ID: 17651785
[TBL] [Abstract][Full Text] [Related]
20. JAB1/CSN5 and the COP9 signalosome. A complex situation.
Chamovitz DA; Segal D
EMBO Rep; 2001 Feb; 2(2):96-101. PubMed ID: 11258719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
